This “series” of monthly podcasts will feature new information and emerging topics that are published as our Editor’s Choice article in the journal. The Podcasts will be hosted by one of the Journal’s editors and include a conversation with the author of the Editor’s choice article along with the author of the featured commentary/editorial that accompanies the lead article.

If you experience trouble listening to the podcasts, please download the mp3 file, right-click (on a PC) or control-click (on a Mac) and choose "Save Link As" to play on your computer.

Five Ways to Access the Podcasts:

  1. Open and download any of the individual files below.
  2. If you have the iTunes media player, you can subscribe to listen to Gynecologic Oncology Podcasts at the iTunes Music Store.
  3. If you have the Google media player, you can subscribe to listen to Gynecologic Oncology Podcasts via Google Podcasts.
  4. Listen and subscribe to the podcast via Spotify at https://open.spotify.com/show/1PSI1VIF5mS77NWgCcs6cl.
  5. For automatic delivery of content of each issue, copy and paste http://www.gynecologiconcology-online.net/pb/assets/raw/Health%20Advance/journals/ygyno/podcasts/ygyno_podcasts_rss.xml to your rss icon RSS reader.

Featured Video

Gynecologic Oncology Podcast on the Future of the Gyn Onc Subspecialty

In this new, Special Edition of the Gynecologic Oncology video podcast, The Future of Gynecologic Oncology: We are at a Crossroads, David E. Cohn, MD, MBA, President of the SGO and Deputy Editor of Gynecologic Oncology, and Warner K. Huh, MD, Immediate Past-President of the SGO, engage in a lively discussion about Dr. Huh’s vision for the SGO and gynecologic oncology as a subspecialty. Initially envisioned as part of Dr. Huh’s Presidential Address for the SGO 2020 Annual Meeting in Toronto, this podcast puts the events of the past year in perspective, while remaining focused on the long-term future of gynecologic oncology.

  1. Immunotherapy Toxicities: A Society of Gynecologic Oncology Podcast

    Leslie Clark
    , MD, Gynecologic Oncologist, University of North Carolina in Chapel Hill


    Róisín O’Cearbhaill, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center
    Ramez Eskander, MD, Gynecologic Oncologist, University of California San Diego

    Dr. Leslie Clark presents a patient case to frame a discussion on the management of immunotherapy-related toxicities in gynecologic cancers. Drs. Róisín O’Cearbhaill and Ramez Eskander provide clinical management strategies for adverse events that gynecologic oncologists commonly encounter, such as diarrhea, rash, and hypothyroidism, as well as their approaches to situations that can be more difficult to discern, such as pneumonitis. This podcast was developed by the Society of Gynecologic Oncology for Gynecologic Oncology.

    Editor’s Choice Paper: Immunotherapy toxicities: An SGO clinical practice statement

    Browse all Gynecologic Oncology audio
  2. May 2022 Editor’s Choice: The ProMisE of molecular classification to standardize care in endometrial cancer

    Hosted by:
    S. Diane Yamada
    , MD, Deputy Editor of Gynecologic Oncology


    Jessica N. McAlpine, MD, University of British Columbia
    G. Larry Maxwell, MD, FACOG, COL(ret) USA, Inova Health System

    Editor’s Choice Paper: Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification

    Editorial: The ProMisE of uniform care for endometrial cancer patients

    Browse all VideoGIE audio
  3. April 2022 Editor’s Choice: Reducing non-surgical readmissions in gynecologic oncology

    Hosted by:
    John Farley
    , MD, Associate Editor of Gynecologic Oncology


    Catherine H. Watson, MD, Vanderbilt University Medical Center
    Larissa Alejandra Meyer, MD MPH, The University of Texas MD Anderson Cancer Center

    Editor’s Choice Paper: Reducing non-surgical readmissions on a gynecologic oncology service

    Editorial: Our dual responsibility of improving quality and questioning the metrics: Reflections on 30-day readmission rate as a quality indicator

    Browse all Gynecologic Oncology audio
  4. March 2022 Editor’s Choice: Improving QOL for patients with cervical cancer: SLN biopsy

    Hosted by:
    Sean C. Dowdy, MD, Associate Editor of Gynecologic Oncology


    Sara Elisabeth Sponholtz, MD, PhD, University of Southern Denmark
    Mario M. Leitao, Jr., MD, Memorial Sloan-Kettering Cancer Center

    Editor’s Choice Paper: SENTIREC – The sentinel node mapping in women with cervical cancer study – Patient-reported early lymphedema and its impact on quality of life

    Editorial: The end of routine lymphadenectomy for the treatment of cervical cancer is rapidly approaching

    Browse all Gynecologic Oncology audio
  5. February 2022 Editor’s Choice: HRD: What does it really mean and are we looking at this the right way?

    Hosted by: 
    Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology



    Elizabeth Swisher, MD, UW Medicine
    Jonathan A Ledermann, MD FRCP FMedSci Professor of Medical Oncology, UCL Cancer Institute
    Editor’s Choice Paper: Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study
    Editorial: Testing for homologous recombination deficiency – does it provide new insights for the use of veliparib?

    Browse all Gynecologic Oncology audio